药物过量导致心脏骤停复苏成功后的差异化结局
该研究为单中心回顾性分析,纳入2012至2017年300例心脏骤停病例,其中28例(9%)归因于药物过量,阿片类占54%。药物过量组更年轻、合并症更少、目击骤停和旁观者心肺复苏比例更低、无灌流时间更长。住院死亡率两组无差异(79% vs 73%,p=0.66),但药物过量组脑死亡率更高(43% vs 6%,p<0.001)。存活出院者中,有利神经功能恢复比例无差异:脑功能分级1-2分为7% vs 7%(p=1.00),改良Rankin量表0-3分为7% vs 9%(p=1.00)。作者认为需要更大规模前瞻性研究以了解该人群的治疗选择和预后工具。
要点
- 药物过量所致心脏骤停患者住院死亡率与非药物过量者无差异(79% vs 73%,p=0.66)。
- 药物过量组脑死亡率显著更高(43% vs 6%,p<0.001),复苏成功后需警惕向脑死亡进展。
- 存活出院者中有利神经功能恢复比例无差异:脑功能分级1-2分7% vs 7%(p=1.00),改良Rankin量表0-3分7% vs 9%(p=1.00)。
- 药物过量组更年轻、合并症更少,但目击骤停和旁观者心肺复苏比例更低、无灌流时间更长。
- 药物过量病例中阿片类占54%,单中心300例中药物过量占9%。
适用人群与场景
- 2012至2017年单中心学术机构的300例心脏骤停病例,其中28例(9%)归因于药物过量。
- 药物过量病例通过入院记录强烈提示药物过量或毒物筛查阳性且不能由用药解释来确认。
研究设计与关键结果
- 研究类型:单中心回顾性分析,纳入2012至2017年300例心脏骤停病例。
- 药物过量组28例(9%),其中阿片类占54%;非药物过量组为其余病例。
- 住院死亡率:药物过量组79% vs 非药物过量组73%,p=0.66,无差异。
- 脑死亡率:药物过量组43% vs 非药物过量组6%,p<0.001,药物过量组更高。
- 存活出院者有利神经功能恢复(脑功能分级1-2分):药物过量组7% vs 非药物过量组7%,p=1.00;改良Rankin量表0-3分:药物过量组7% vs 非药物过量组9%,p=1.00。
- 药物过量组更年轻、合并症更少、目击骤停或旁观者心肺复苏比例更低、无灌流时间更长。
证据类型、等级与局限
- 证据类型:单中心回顾性分析。
- 作者结论:尽管神经功能恢复和出院存活率与非药物过量者相似,药物过量所致心脏骤停患者更可能进展为脑死亡。
- 局限:原文未报告局限性。
对床旁实践的改变
- 药物过量所致心脏骤停患者复苏成功后,住院死亡率与非药物过量者无差异,但脑死亡率更高(43% vs 6%),床旁需关注神经功能评估与脑死亡进展。
- 药物过量组目击骤停和旁观者心肺复苏比例更低、无灌流时间更长,提示该类患者院前识别与复苏启动可能不足。
- 作者认为需要更大规模前瞻性研究以了解该人群的潜在治疗选择和预后工具。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Data pertaining to clinical characteristics and outcomes of cardiac arrest (CA) due to drug overdose (ODCA) are limited. We hypothesized that patients with ODCA would have binary outcomes (brain death or functional recovery) compared to patients in whom CA was due to another etiology.
METHODS: We performed a retrospective analysis of CA cases from a single academic institution from 2012 to 2017. ODCA cases were ascertained by admission notes strongly suggestive of OD or positive toxicology screens not explained by medication administration. Clinical characteristics and outcomes were extracted from medical records, and regression modeling was used to compare ODCA and non-ODCA patients.
RESULTS: Of the 300 CA cases in this analysis, 28 (9%) were attributed to drug overdose, with opioids accounting for 54%. ODCA patients were younger, had fewer comorbidities, were less likely to have witnessed arrests or bystander cardiopulmonary resuscitation, and had longer downtimes. Inpatient mortality did not differ between cohorts (79% ODCA, 73% non-ODCA, p = 0.66), but ODCA was associated with higher rates of brain death (43%, 6%, p < 0.001). Of patients who survived to discharge, there was no difference in the likelihood of favorable neurological recovery, defined as Cerebral Performance Category score of 1-2 (7%, 7%, p = 1.00) or modified Rankin Scale score of 0-3 (7%, 9%, p = 1.00).
CONCLUSIONS: Despite similar neurological recovery and survival rates to hospital discharge, ODCA patients were more likely than non-ODCA patients to progress to brain death. Larger prospective studies analyzing ODCA are needed to better understand potential treatment options and prognostic tools in this cohort.
参考来源
- Ormseth CH, Maciel CB, Zhou SE, et al. Differential outcomes following successful resuscitation in cardiac arrest due to drug overdose. Resuscitation. 2019. PMID: 30965094. doi:10.1016/j.resuscitation.2019.04.004
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。